Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.

Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T, Wang G.

Int J Antimicrob Agents. 2012 May;39(5):402-6. doi: 10.1016/j.ijantimicag.2012.02.003.

2.

Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds.

Wang G, Hanke ML, Mishra B, Lushnikova T, Heim CE, Chittezham Thomas V, Bayles KW, Kielian T.

ACS Chem Biol. 2014 Sep 19;9(9):1997-2002. doi: 10.1021/cb500475y.

3.

Ab initio design of potent anti-MRSA peptides based on database filtering technology.

Mishra B, Wang G.

J Am Chem Soc. 2012 Aug 1;134(30):12426-9. doi: 10.1021/ja305644e.

4.

Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.

Li SA, Lee WH, Zhang Y.

Antimicrob Agents Chemother. 2012 Jun;56(6):3309-17. doi: 10.1128/AAC.06304-11.

5.

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Sakoulas G, Okumura CY, Thienphrapa W, Olson J, Nonejuie P, Dam Q, Dhand A, Pogliano J, Yeaman MR, Hensler ME, Bayer AS, Nizet V.

J Mol Med (Berl). 2014 Feb;92(2):139-49. doi: 10.1007/s00109-013-1100-7.

6.

Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Xiong YQ, Hady WA, Deslandes A, Rey A, Fraisse L, Kristensen HH, Yeaman MR, Bayer AS.

Antimicrob Agents Chemother. 2011 Nov;55(11):5325-30. doi: 10.1128/AAC.00453-11.

7.

In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus.

Zhang Y, Teng D, Wang X, Mao R, Cao X, Hu X, Zong L, Wang J.

Appl Microbiol Biotechnol. 2015 Aug;99(15):6255-66. doi: 10.1007/s00253-015-6394-7.

PMID:
25620367
8.
9.

Highly selective end-tagged antimicrobial peptides derived from PRELP.

Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A.

PLoS One. 2011 Jan 27;6(1):e16400. doi: 10.1371/journal.pone.0016400.

10.
11.

Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.

Mohamed MF, Hamed MI, Panitch A, Seleem MN.

Antimicrob Agents Chemother. 2014 Jul;58(7):4113-22. doi: 10.1128/AAC.02578-14.

12.

Community-acquired meticillin-resistant Staphylococcus aureus strain USA300 resists staphylococcal protein A modulation by antibiotics and antimicrobial peptides.

Cardot Martin E, Michel A, Raynal B, Badiou C, Laurent F, Vandenesch F, Etienne J, Lina G, Dumitrescu O.

Int J Antimicrob Agents. 2015 Jan;45(1):19-24. doi: 10.1016/j.ijantimicag.2014.08.009.

PMID:
25450803
13.

Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.

Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H.

Molecules. 2016 Jan 6;21(1):62. doi: 10.3390/molecules21010062.

14.

Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.

Taira J, Kida Y, Yamaguchi H, Kuwano K, Higashimoto Y, Kodama H.

J Pept Sci. 2010 Nov;16(11):607-12. doi: 10.1002/psc.1270.

PMID:
20648478
15.

Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA.

Tunçbilek M, Kiper T, Altanlar N.

Eur J Med Chem. 2009 Mar;44(3):1024-33. doi: 10.1016/j.ejmech.2008.06.026.

PMID:
18718694
16.

Di-K19Hc, an antimicrobial peptide as new ototopical agent for treatment of otitis media.

Lee YS, Kim YJ, Choi SH, Shin KH, Jang WS, Lee IH, Chung JW.

Acta Otolaryngol. 2010 Aug;130(8):897-903. doi: 10.3109/00016480903536036.

PMID:
20100130
17.

Antibacterial activity of THAM Trisphenylguanide against methicillin-resistant Staphylococcus aureus.

Weaver AJ Jr, Shepard JB, Wilkinson RA, Watkins RL, Walton SK, Radke AR, Wright TJ, Awel MB, Cooper C, Erikson E, Labib ME, Voyich JM, Teintze M.

PLoS One. 2014 May 19;9(5):e97742. doi: 10.1371/journal.pone.0097742.

18.
19.

In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.

Fernandez J, Hilliard JJ, Abbanat D, Zhang W, Melton JL, Santoro CM, Flamm RK, Bush K.

Antimicrob Agents Chemother. 2010 Jan;54(1):116-25. doi: 10.1128/AAC.00642-09.

20.

IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.

Cirioni O, Silvestri C, Pierpaoli E, Barucca A, Kamysz W, Ghiselli R, Scalise A, Brescini L, Castelli P, Orlando F, Kamysz E, Guerrieri M, Giacometti A, Provinciali M.

J Med Microbiol. 2013 Oct;62(Pt 10):1552-8. doi: 10.1099/jmm.0.057414-0.

PMID:
23813277
Items per page

Supplemental Content

Support Center